← Back to Search

sleep education program for Sleep

N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Community-dwelling
Have no history of cognitive impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the last session of the intervention
Awards & highlights

Study Summary

This trial will use evidence-based techniques to improve symptoms of depression, anxiety, and poor sleep in Alzheimer's patients and their caregivers during the COVID-19 pandemic.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You live independently in the community, not in a nursing home or hospital.
Select...
You have never had a problem with your memory or thinking skills.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after the posttreatment assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the posttreatment assessment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pittsburgh Sleep Quality Index score
Sleep efficiency-Actigraphy
Secondary outcome measures
Total scores on the Cornell Scale for Depression in Dementia
Total scores on the Generalized Anxiety Disorder-7
Total scores on the Patient Health Questionnaire-9
+1 more
Other outcome measures
Adherence to homework
Attrition rate
Interventionist adherence

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment groupExperimental Treatment1 Intervention
6 weekly sleep education program
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
sleep education program
2021
N/A
~30

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,518 Previous Clinical Trials
10,278,731 Total Patients Enrolled
3 Trials studying Sleep
581 Patients Enrolled for Sleep

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the desired outcome of this clinical investigation?

"The primary objective of this clinical trial, the results of which will be assessed immediately after completion of the intervention, is to evaluate Pittsburgh Sleep Quality Index scores. Secondary outcomes are Total scores on Cornell Scale for Depression in Dementia (range 0-38 with higher numbers representing more severe depression symptoms), Patient Health Questionnaire-9 (0-27; increased values signify worse depressive symptoms among caregivers) and Generalized Anxiety Disorder-7 (0-21; greater numerical value indicate greater anxiety levels in caretakers)."

Answered by AI

Are applicants still being considered for this investigation?

"Affirmative. Clinicaltrials.gov details that recruitment for this medical trial, which was launched on August 20th 2021, is currently in progress. 15 test subjects are needed at one location to complete the study's objectives."

Answered by AI

What is the current participant count in this experiment?

"Indeed, the clinicaltrials.gov database indicates that this experiment is presently recruiting volunteers. It was uploaded on August 20th 2021 with a final update occurring on September 1st 2022 and requires 15 participants from one site in particular."

Answered by AI
~8 spots leftby Mar 2025